Biomea Fusion, Inc. (BMEA) vs Cellectis S.A. (CLLS)
Biomea Fusion, Inc. and Cellectis S.A. are both Biotechnology companies. Biomea Fusion, Inc. and Cellectis S.A. are of similar size ($108.0M and $103.4M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −102.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Biomea Fusion, Inc. leads on 8 and Cellectis S.A. on 5.
Valuation
Profitability
| Metric | BMEA | CLLS | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (90.88%) | 0.00% |
| Net margin | 0.00% | (102.34%) | 0.00% |
| Free cash flow margin | 0.00% | (68.63%) | 0.00% |
| Return on equity | (164.14%) | (94.54%) | (57.72%) |
| Return on assets | (59.14%) | (21.02%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack